Rivaroxaban for preventing venous thromboembolism in high-risk ambulatory patients with cancer: Rationale and design of the CASSINI trial

Alok A. Khorana, Saroj Vadhan-Raj, Nicole M. Kuderer, Ted Wun, Howard Liebman, Gerald Soff, Chandra Belani, Eileen M. O'Reilly, Robert McBane, John Eikelboom, C. V. Damaraju, Karen Beyers, Flavia Dietrich, Ajay K. Kakkar, Hanno Riess, Renata D.Alpino Peixoto, Gary H. Lyman

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Rivaroxaban for preventing venous thromboembolism in high-risk ambulatory patients with cancer: Rationale and design of the CASSINI trial'. Together they form a unique fingerprint.

Medicine & Life Sciences